
Publication|Articles|April 7, 2026
- Re-adding EXPAREL to Formulary: The Pharmacist Perspective
Re-adding EXPAREL to Formulary: The Pharmacist Perspective
Author(s)Pacira Pharmaceuticals, Inc.
Key Takeaways
This article is sponsored by Pacira Pharmaceuticals, Inc.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
5








































































































































